Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Subcutaneous adipose tissue blood flow and vasomotion in morbidly obese patients: long term effect of gastric bypass surgery.

Rossi M, Nannipieri M, Anselmino M, Guarino D, Franzoni F, Pesce M.

Clin Hemorheol Microcirc. 2012;51(3):159-67. doi: 10.3233/CH-2011-1517.

PMID:
22240375
2.

Skin vasodilator function and vasomotion in patients with morbid obesity: effects of gastric bypass surgery.

Rossi M, Nannipieri M, Anselmino M, Pesce M, Muscelli E, Santoro G, Ferrannini E.

Obes Surg. 2011 Jan;21(1):87-94. doi: 10.1007/s11695-010-0286-9.

PMID:
20886308
3.

Laser-Doppler flowmetry reveals rapid perfusion changes in adipose tissue of lean and obese females.

Wellhöner P, Rolle D, Lönnroth P, Strindberg L, Elam M, Dodt C.

Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1025-30. Epub 2006 Jun 20.

PMID:
16787964
4.

Laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy achieve comparable weight loss at 1 year.

Yaghoubian A, Tolan A, Stabile BE, Kaji AH, Belzberg G, Mun E, Zane R.

Am Surg. 2012 Dec;78(12):1325-8.

PMID:
23265120
5.

Aerobic endurance training improves weight loss, body composition, and co-morbidities in patients after laparoscopic Roux-en-Y gastric bypass.

Shang E, Hasenberg T.

Surg Obes Relat Dis. 2010 May-Jun;6(3):260-6. doi: 10.1016/j.soard.2010.01.006. Epub 2010 Feb 6. Retraction in: Surg Obes Relat Dis. 2012 May-Jun;8(3):370.

PMID:
20510289
6.
7.

Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.

Stoeckli R, Chanda R, Langer I, Keller U.

Obes Res. 2004 Feb;12(2):346-50.

8.

Failure to increase postprandial blood flow in subcutaneous adipose tissue is associated with tissue resistance to adrenergic stimulation.

Ardilouze JL, Sotorník R, Dennis LA, Fielding BA, Frayn KN, Karpe F.

Diabetes Metab. 2012 Feb;38(1):27-33. doi: 10.1016/j.diabet.2011.06.005. Epub 2011 Aug 23.

PMID:
21865069
9.

Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.

Gómez-Ambrosi J, Rodríguez A, Catalán V, Ramírez B, Silva C, Rotellar F, Gil MJ, Salvador J, Frühbeck G.

Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15. Epub 2007 Dec 10.

PMID:
18081728
10.

Long-limb gastric bypass in the superobese. A prospective randomized study.

Brolin RE, Kenler HA, Gorman JH, Cody RP.

Ann Surg. 1992 Apr;215(4):387-95.

11.

Dysregulation of subcutaneous adipose tissue blood flow in overweight postmenopausal women.

Andersson J, Sjöström LG, Karlsson M, Wiklund U, Hultin M, Karpe F, Olsson T.

Menopause. 2010 Mar;17(2):365-71. doi: 10.1097/gme.0b013e3181c12b26.

PMID:
19940788
12.

Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass.

Gómez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catalán V, Rodríguez A, Jesús Gil M, Frühbeck G.

Obes Surg. 2006 Mar;16(3):262-9.

PMID:
16545156
13.

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.

Dorman RB, Serrot FJ, Miller CJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Bantle JP, Ikramuddin S.

Ann Surg. 2012 Feb;255(2):287-93. doi: 10.1097/SLA.0b013e318232b033.

PMID:
21975321
14.

Return to work after gastric bypass in Medicaid-funded morbidly obese patients.

Wagner AJ, Fabry JM Jr, Thirlby RC.

Arch Surg. 2007 Oct;142(10):935-40; discussion 941.

PMID:
17938305
15.

Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial.

Hedberg J, Sundbom M.

Surg Obes Relat Dis. 2012 May-Jun;8(3):338-43. doi: 10.1016/j.soard.2012.01.014. Epub 2012 Feb 1.

PMID:
22425057
16.

Differential loss of fat and lean mass in the morbidly obese after bariatric surgery.

Zalesin KC, Franklin BA, Lillystone MA, Shamoun T, Krause KR, Chengelis DL, Mucci SJ, Shaheen KW, McCullough PA.

Metab Syndr Relat Disord. 2010 Feb;8(1):15-20. doi: 10.1089/met.2009.0012.

PMID:
19929598
17.

Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss.

Leyvraz C, Verdumo C, Suter M, Paroz A, Calmes JM, Marques-Vidal PM, Giusti V.

Obes Facts. 2012;5(3):440-51. doi: 10.1159/000341137. Epub 2012 Jun 30.

18.

Effect of Roux-en-Y gastric bypass-induced weight loss on the transcriptomic profiling of subcutaneous adipose tissue.

González-Plaza JJ, Gutiérrez-Repiso C, García-Serrano S, Rodriguez-Pacheco F, Garrido-Sánchez L, Santiago-Fernández C, García-Arnés J, Moreno-Ruiz FJ, Rodríguez-Cañete A, García-Fuentes E.

Surg Obes Relat Dis. 2016 Feb;12(2):257-63. doi: 10.1016/j.soard.2015.07.007. Epub 2015 Jul 13.

PMID:
26615868
19.

Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports.

Ciangura C, Corigliano N, Basdevant A, Mouly S, Declèves X, Touraine P, Lloret-Linares C.

Contraception. 2011 Dec;84(6):649-51. doi: 10.1016/j.contraception.2011.03.015. Epub 2011 May 8.

PMID:
22078197
20.

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study.

Chouillard EK, Karaa A, Elkhoury M, Greco VJ; Intercontinental Society of Natural Orifice, Endoscopic, and Laparoscopic Surgery (i-NOELS).

Surg Obes Relat Dis. 2011 Jul-Aug;7(4):500-5. doi: 10.1016/j.soard.2011.01.037. Epub 2011 Mar 8.

PMID:
21459682

Supplemental Content

Support Center